UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000042419 |
|---|---|
| Receipt number | R000048423 |
| Scientific Title | Effect of coffee bean extract on postprandial blood glucose level |
| Date of disclosure of the study information | 2020/11/11 |
| Last modified on | 2020/12/09 09:24:01 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of coffee bean extract on postprandial blood glucose level
Acronym
Effect of coffee bean extract on postprandial blood glucose level
Scientific Title
Effect of coffee bean extract on postprandial blood glucose level
Scientific Title:Acronym
Effect of coffee bean extract on postprandial blood glucose level
Region
| Japan |
Condition
Condition
Healthy subject
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the effect of coffee bean extract on postprandial blood glucose level.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Postprandial blood glucose level up to 2 hours after intake
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Single blind -participants are blinded
Control
Placebo
Stratification
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
No need to know
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Breakfast containing coffee bean extract
Interventions/Control_2
Breakfast without coffee bean extract
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 25 | years-old | >= |
Gender
Male
Key inclusion criteria
1. Aged 20 to 25 years old
2. Body mass index less than 30 kg/m2
3. Healthy condition enough to complete the intervention safely
4. Subject who voluntarily participates with written consent
Key exclusion criteria
1. Subject who has glucose metabolism disorders, endocrine disorders, kidney/liver and digestive organ diseases.
2. Subject who has prescribed drugs.
3. Subject diagnosed to have cardiovascular disorder.
4. Subject who has type 1 or type 2 diabetes mellitus.
5. Subject who was judged to have symptom needed to treat or reexamine at health check within a year.
6. Subject who participated in another trial within 3 months.
7. Subject who took illegal drug within 6 months.
8. Subject who was addicted to alcohol or other drug within 6 months
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Yoshio |
| Middle name | Suzuki |
| Last name | Suzuki |
Organization
Juntendo University
Division name
Graduate School of Health and Sports Science
Zip code
2701695
Address
1-1, Hiragagakuendai, Inzai, Chiba
TEL
+81476981001
yssuzuki@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Yoshio |
| Middle name | |
| Last name | Suzuki |
Organization
Juntendo University
Division name
Graduate School of Health and Sports Science
Zip code
2701695
Address
1-1, Hiragagakuendai, Inzai, Chiba
TEL
+81476981001
Homepage URL
yssuzuki@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University, Graduate School of Health & Sports Science
Institute
Department
Personal name
Funding Source
Organization
self-funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics committee of Juntendo University Graduate School of Sports and Health Science
Address
1-1, Hiragagakuendai, Inzai, Chiba
Tel
+81476981001
sc-kyomu@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
順天堂大学（千葉県）
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 11 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2020 | Year | 11 | Month | 10 | Day |
Date of IRB
| 2020 | Year | 11 | Month | 10 | Day |
Anticipated trial start date
| 2020 | Year | 11 | Month | 10 | Day |
Last follow-up date
| 2020 | Year | 12 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2020 | Year | 11 | Month | 11 | Day |
Last modified on
| 2020 | Year | 12 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048423
